Symtuza protease inhibitor regimen maintains viral suppression for a year
Long-acting monoclonal antibody effective against multidrug-resistant HIV
Rapid fibrosis progression in large proportion of HIV-positive gay men after acute HCV
Impact of side-effects on retention in HIV care is underestimated, African study suggests
Many gay/bisexual men currently taking PrEP would switch to injectable forms of the therapy should it become available
People with HIV/HCV co-infection have an increased risk of cardiovascular disease compared to people with HIV alone
HIV diagnoses in the UK fell in gay men last year for the first time since the mid-1990s, Public Health England confirms
Virally suppressed people have “effectively no risk” of transmitting HIV, says US CDC: but how many are suppressed?
